The Web site for Thomas Jefferson University, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor, is it intended to create any physician-patient relationship.
Stool softener is found among people who take Linzess, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Miralax, and have Irritable bowel syndrome. This review analyzes which people have Stool softener with Linzess. It is created by eHealthMe based on reports of 4,320 people who have side effects when taking Linzess from FDA, and is updated regularly.
LINZESS is a once-daily capsule that helps relieve the chronic abdominal pain and constipation associated with IBS-C and constipation and hard stools associated with CIC. The recommended dose is 290 mcg for IBS-C patients and 145 mcg for CIC patients. LINZESS binds to the GC-C receptor locally in the intestine, with no measurable blood plasma concentrations, resulting in an increase in both intracellular and extracellular concentrations of cyclic guanosine monophosphate (cGMP).